Dr Sharad Kumar Suthar
Assistant Professor
Incheon
Expertise:
Multidisciplinary Chemistry
48
Publications
2
Projects
928
Scopus Citations
853
CrossRef
5 Years 7 Months Total Experience
Scopus
928
Citations
15
h-index
CrossRef
853
Citations
15
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
Brain Pool Fellowship Grant No. 2021H1D3A2A02044867 (2021-2023
2021
National Research Foundation (NRF) of South Korea
Editor of Distinction Award
2026
Scientific Reports (Springer Nature)
Outstanding Contribution in Reviewing Award
2015
European Journal of Medicinal Chemistry
Community & Membership
No Data Found
There is currently nothing to display here.
American Chemical Society, USA
Membership No. 32333504The Royal Society of Chemistry, United Kingdom
Membership ID 749399Personal Details
Doctor of Philosophy
2014
National Institute of Virology
Master of Pharmacy
2010
N/A
Bachelor of Pharmacy
2008
South Texas Veterans Health Care System, San Antonio, Texas, USA
Assistant Professor
Mar 2026 – Present
Unknown Organization
Research Professor
Aug 2021 – Feb 2026
Unknown Organization
Post-Doctoral Fellow
Mar 2015 – Aug 2015
Seoul National University, South Korea
Chemical Sciences
Scholarly Work
Development of PET ligand for molecular imaging of synucleinopathy
CompletedDevelopment of the first non-muscle myosin-2 (NM-2) specific inhibitor
CompletedNo Data Found
There is currently nothing to display here.
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
HK40094972
Filed :
01-12-2023
Published :
26-01-2024
Published
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
US12421243B2
Filed :
08-09-2023
Published :
23-09-2025
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
US11845758B2
Filed :
30-06-2023
Published :
19-12-2023
Granted
(+)-Cyanidan-3-ol targets cip2a-pp2a axis to inhibit epidermoid squamous cell carcinoma growth
Jitender Monga
Sharad Kumar Suthar
Manu Sharma
-
Application No. :
IN202111052304
Filed :
15-11-2021
Published :
15-12-2023
Published
Development of method for chemical synthesis of oleanolic acid from lantadenes
M Sharma
SK Suthar
Jitender Monga
Vipin Saini
Nikhil Gupta
-
Application No. :
IN202111031305
Filed :
12-07-2021
Published :
15-12-2023
Published
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
US11746112B2
Filed :
18-04-2019
Published :
05-09-2023
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
EP3781263B1
Filed :
18-04-2019
Published :
12-07-2023
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
EP4276102A3
Filed :
18-04-2019
Published :
06-12-2023
Published
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
CN117924285A
Filed :
18-04-2019
Published :
26-04-2024
Published
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
CN112334191B
Filed :
18-04-2019
Published :
10-12-2024
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
IN542344
Filed :
18-04-2019
Published :
27-11-2020
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
AU2019256801C1
Filed :
18-04-2019
Published :
13-02-2025
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
IL278105B2
Filed :
18-04-2019
Published :
01-05-2024
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
JP7463344B2
Filed :
18-04-2019
Published :
08-04-2024
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
KR20210010465A
Filed :
18-04-2019
Published :
27-01-2021
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
SG11202010177UA
Filed :
18-04-2019
Published :
27-11-2020
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
PH12020551734B1
Filed :
18-04-2019
Published :
07-06-2021
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
PT3781263T
Filed :
18-04-2019
Published :
13-10-2023
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
MX/a/2020/011020
Filed :
18-04-2019
Published :
08-01-2021
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
MA52298
Filed :
18-04-2019
Published :
24-02-2021
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
ES2963548T3
Filed :
18-04-2019
Published :
27-03-2024
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
PL3781263T3
Filed :
18-04-2019
Published :
22-01-2024
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
SI3781263T1
Filed :
18-04-2019
Published :
31-01-2024
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
DK3781263T3
Filed :
18-04-2019
Published :
02-10-2023
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
FI3781263T3
Filed :
18-04-2019
Published :
15-09-2023
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
HU231285B1
Filed :
18-04-2019
Published :
28-08-2022
Granted
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
JP2024075759A
Filed :
18-04-2019
Published :
04-06-2024
Published
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
CA3097479A1
Filed :
18-04-2019
Published :
24-10-2019
Published
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
BR112020021347A2
Filed :
18-04-2019
Published :
19-01-2021
Published
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
A Málnási-Csizmadia
M Gyimesi
A Szabó
P Hári
SK Suthar
M Kovács
ÁI Horváth
M Pénzes
I Lorincz
J Répási
Z Szonyegi
Z Simon
L Végner
S Bátori
V Horváth
-
Patent No. :
TR2023/012100
Filed :
18-04-2019
Published :
23-10-2023
Granted
An economical and improved isolation process of antitumor triterpenoid Lantadene B from weed Lantana camara L
Manu Sharma
S Sharad Kumar
-
Patent No. :
IN329887
Filed :
25-06-2012
Published :
14-02-2014
Granted
An improved process of conversion of Lantadene A and B to reduced Lantadene A and B
Manu Sharma
S Sharad Kumar
-
Patent No. :
IN302295
Filed :
04-10-2011
Published :
05-04-2013
Granted
Scholarly Publications
Phytochemical, antioxidant and antimicrobial study of flowers of Nyctanthes arbor-tristis Linn
Scopus: 4
Localized covalent targeting of NMDA receptors reprograms behavior
Recent Developments in Chimeric NSAIDs as Anticancer Agents: Teaching an Old Dog a New Trick
Design, synthesis, and biological evaluation of oxindole derivatives as antidepressive agents
Molecular docking and biological evaluation of hydroxy-substituted (<i>Z</i>)-3-benzylideneindolin-2-one chalcones for the lead identification as tyrosinase inhibitors
Recent Developments in Chimeric NSAIDs as Safer Anti-Inflammatory Agents
Design, synthesis, docking study & antibacterial evaluation of 1,3-diarylpyrazolyl substituted indolin-2-ones
10.35652/IGJPS.2014.117
Crossref: 7
Synthesis, docking study & anticancer evaluation of novel 3-phenyl-2-(3-aryl-1-phenyl-1H-pyrazol-4-yl)thiazolidin-4-ones
10.35652/IGJPS.2014.119
Crossref: 1
Showing 1 to 8 of 48 publications